Albireo Pharma, Inc.
ALBODelisted Mar 2, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001322505
Albireo Pharma, Inc. was delisted on Mar 2, 2023; its insiders filed their last Form 4 on Mar 3, 2023; 96 institutions reported holding it in 13F filings for Q4 2022, worth $401.7M in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding Albireo Pharma, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 3 | 1 | −2 |
| Shares | 46.1K | 1 | −46.1K (−100.0%) |
| Value | $2.04M | $756 | −$2.04M (−100.0%) |
New holders (0)
Institutions that held Albireo Pharma, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
None.
Sold out (2)
Institutions that held Albireo Pharma, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| DekaBank Deutsche Girozentrale | 45,000 | $1.99M |
| GW&K Investment Management, LLC | 1,080 | $48.0K |